Serology News
-
New antibody detection platform offers accelerated multiplex detection of antibodies against pathogens or autoantibodies against biomarkers
VeraPrep Antibody Detection kit, to be introduced at AACC, allows researchers to measure antibodies against any antigen of interest in serum, plasma or saliva. Austin, TX, September 27, 2021 -- Veravas, Inc., an early-stage diagnostics company, has announced the development of its VeraPrep™ Antibody Detection Kit, a new development platform that provides scientists with a ...
-
ECOMONDO and KEY ENERGY: IEG ready to re-start in total safety
Rimini, 22 July 2021 – Green Pass and Safe Travel so that exhibitors and visitors are guaranteed the highest possible level of security. IEG - Italian Exhibition Group S.p.A., after having been the first in Italy to develop the SAFE BUSINESS protocol in April 2020 and having then followed up with numerous initiatives aimed at global security, is now adding further elements to ensure the ...
-
ImmunogenX and Mayo Clinic Successfully Complete the CeliacShield Trial
ImmunogenX is happy to announce the successful completion of the CeliacShield trial (NCT03585478). This gluten-challenge trial measured several outcomes including histology, symptoms, serology, and gluten in urine. The trial also incorporated our CypCel diagnostic technology as a monitor of small intestinal villous health utilizing the drug biomarker simvastatin as measured in blood samples. ...
-
The JRC releases new reference materials for the quality control of SARS-CoV-2 antibody tests
The JRC released two new reference materials, developed to function as quality assurance tools for the SARS-CoV-2 antibody tests used to verify if an individual has been infected by the COVID-19 virus. Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: "The correct functioning of antibody tests is particularly important in epidemiological investigations to ...
-
Thermo Fisher Scientific Further Expands COVID-19 Test Portfolio with Two New Antibody Tests
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today introduced two new SARS-CoV-2 antibody tests: the Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test, and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. These new tests for detecting COVID-19 antibodies expand the company's leading response to the pandemic, which ranges from molecular diagnostic ...
-
NEC OncoImmunity AS and Oslo University Hospital team up to develop a diagnostic for COVID-19 using artificial intelligence
NEC OncoImmunity AS (NOI), a subsidiary of NEC Corporation (NEC), and Oslo University Hospital (OUH) are pleased to announce that they have recently been awarded a prestigious grant from the Research Council of Norway (RCN) to develop an artificial intelligence (AI) platform that will enable the rapid design of T-cell diagnostics for emerging or endemic infectious diseases. The project will ...
-
Thermo Fisher Scientific Launches New MAS Omni Infectious Disease Quality Controls
Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II. Serology testing for infectious diseases continues to be on the rise and newer instrument platforms are ...
-
Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced it will expand its response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic. The new test is the result of ongoing collaboration between all three organizations, including clinical evaluation and support from Mayo Clinic. Thermo Fisher ...
-
Abbott receives FDA approval for first fully automated blood test for `kissing bug` disease
Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test. The test is a fully automated blood screening assay that can detect antibodies to Trypansoma cruzi (T. cruzi), a parasite found only in the Americas and most commonly acquired through contact with the blood-sucking triatomine or "kissing bug." ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you